EU approves AstraZeneca’s Lynparza for patients with germline BRCA-mutated HER2-negative…
It is the first and only approved medicine targetting BRCA mutations in early breast cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
adjuvant treatment
European Commission approves Roche’s Tecentriq as adjuvant treatment for early-stage NSCLC
The approval marks Tecentriq’s sixth lung cancer indication in Europe